ITALIANO, A., Gambardella, V., Accordino, M., Bedard, P., Cervantes, A., Hamilton, E., . . . Saura Manich, C. (2025). Safety overview and management of inavolisib alone and in combination therapies in PIK3CA-mutated, HR-positive, HER2-negative advanced breast cancer (GO39374).
Citación estilo ChicagoITALIANO, ANTOINE, Valentina Gambardella, Melissa Accordino, Philippe Bedard, Andrés Cervantes, Erika Hamilton, Mafalda Oliveira, y Cristina Saura Manich. Safety Overview and Management of Inavolisib Alone and in Combination Therapies in PIK3CA-mutated, HR-positive, HER2-negative Advanced Breast Cancer (GO39374). 2025.
Cita MLAITALIANO, ANTOINE, et al. Safety Overview and Management of Inavolisib Alone and in Combination Therapies in PIK3CA-mutated, HR-positive, HER2-negative Advanced Breast Cancer (GO39374). 2025.